Jose Manuel Valdivielso Revilla

Fernández, LM; Sánchez-Alvarez, JE; de la Tassa, CM; Fernández, JJB; María, V; Fernández, E; Valdivielso, JM; Betriu, A

Risk factors associated with valvular calcification in patients with chronic kidney disease. Analysis of NEFRONA study

NEFROLOGIA 41 337-346. 01/05/2021.

[doi:10.1016/j.nefro.2020.08.012]

Rodrigues-Diez, RR; Tejera-Muñoz, A; Orejudo, M; Marquez-Exposito, L; Santos, L; Rayego-Mateos, S; Cantero-Navarro, E; Tejedor-Santamaria, L; Marchant, V; Ortiz, A; Egido, J; Mezzano, S; Selgas, R; Navarro-González, JF; Valdivielso, JM; Lavoz, C; Ruiz-Ortega, M

Interleukin-17A: Potential mediator and therapeutic target in hypertension.

NEFROLOGIA 41 244-257. 01/05/2021.

[doi:10.1016/j.nefro.2020.11.009]

Kosanovic M; Llorente A; Glamoclija S; Valdivielso JM; Bozic M

Extracellular Vesicles and Renal Fibrosis: An Odyssey toward a New Therapeutic Approach.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 22 -. 09/04/2021.

[doi:10.3390/ijms22083887]

Del Vecchio, L; Ekart, R; Ferro, CJ; Malyszko, J; Mark, PB; Ortiz, A; Sarafidis, P; Valdivielso, JM; Mallamaci, F; ERA-EDTA European Renal and Cardiovascular Medicine Working (EURECA-m) Group

Intravenous iron therapy and the cardiovascular system: risks and benefits.

Clinical Kidney Journal 14 1067-1076. 01/04/2021.

[doi:10.1093/ckj/sfaa212]

Gorriz JL; Arroyo D; D'Marco L; Torra R; Tomás P; Puchades MJ; Panizo N; Pantoja J; Montomoli M; Llisterri JL; Pallares-Carratalá V; Valdivielso JM

Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.

BMC Nephrology 22 110-110. 25/03/2021.

[doi:10.1186/s12882-021-02313-1]

Sánchez M; Sánchez E; Bermúdez-López M; Torres G; Farràs-Sallés C; Pamplona R; Castro-Boqué E; Valdivielso JM; Purroy F; Martínez-Alonso M; Godoy P; Mauricio D; Fernández E; Hernández M; Rius F; Lecube A

Clinical Usefulness of Anthropometric Indices to Predict the Presence of Prediabetes. Data from the ILERVAS Cohort.

Nutrients 13 1-15. 19/03/2021.

[doi:10.3390/nu13031002]

Sapiña-Beltrán E; Gracia-Lavedan E; Torres G; Gaeta AM; Paredes J; Mayoral A; Fernández E; Bermúdez-López M; Valdivielso JM; Farràs-Salles C; Pamplona R; Lecube A; de Batlle J; Barbé F; Dalmases M

Prevalence of Obstructive Sleep Apnoea and Its Association With Atherosclerotic Plaques in a Cohort of Subjects With Mild-Moderate Cardiovascular Risk.

ARCHIVOS DE BRONCONEUMOLOGIA 58 490-497. 13/02/2021.

[doi:10.1016/j.arbres.2021.01.026]

Mark PB; Vecchio LD; Valdivielso JM; Malyszko J

Same rhythm, different song-approaches to atrial fibrillation management by cardiologists and nephrologists.

Clinical Kidney Journal 14 9-13. 01/01/2021.

[doi:10.1093/ckj/sfaa146]

Cambray S; Bermudez-Lopez M; Bozic M; Valdivielso JM; NEFRONA investigators

Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease.

Clinical Kidney Journal 13 1017-1024. 01/12/2020.

[doi:10.1093/ckj/sfaa014]

Bermudez-Lopez, M; Forne, C; Cambray, S; Bozic, M; Valdivielso, JM

OUTCOMES AND HEALTHCARE RESOURCES UTILIZATION DIFFERENCES IN PATIENTS WITH AND WITHOUT SECONDARY HYPERPARATHYROIDISM FROM THE NEFRONA COHORT

VALUE IN HEALTH 23 753-753. 01/12/2020.

Marchant, V; Tejera-Munoz, A; Marquez-Exposito, L; Rayego-Mateos, S; Rodrigues-Diez, RR; Tejedor, L; Santos-Sanchez, L; Egido, J; Ortiz, A; Valdivielso, JM; Fraser, DJ; Lopez-Cabrera, M; Selgas, R; Ruiz-Ortega, M

IL-17A as a Potential Therapeutic Target for Patients on Peritoneal Dialysis.

Biomolecules 10 1-36. 24/09/2020.

[doi:10.3390/biom10101361]

Sumida K; Nadkarni GN; Grams ME; Sang Y; Ballew SH; Coresh J; Matsushita K; Surapaneni A; Brunskill N; Chadban SJ; Chang AR; Cirillo M; Daratha KB; Gansevoort RT; Garg AX; Iacoviello L; Kayama T; Konta T; Kovesdy CP; Lash J; Lee BJ; Major RW; Metzger M; Miura K; Naimark DMJ; Nelson RG; Sawhney S; Stempniewicz N; Tang M; Townsend RR; Traynor JP; Valdivielso JM; Wetzels J; Polkinghorne KR; Heerspink HJL

Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis.

ANNALS OF INTERNAL MEDICINE 173 426-435. 15/09/2020.

[doi:10.7326/M20-0529]